Concepedia
Statistics
Publications
1
Citations
14
H-Index
Active since
2019
Affiliations
Novartis (United States)(Current)
Shigemi Fukami is an author at Novartis (United States).
Publications per year
2019–2019
Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models
Shigemi Fukami, D. Tomioka, Yutaka Murakami et al. · BMC Research Notes · 2019 · 14 citations · Full text
1–1 of 1